Trials / Completed
CompletedNCT01777698
Body Composition Analysis in Patients Undergoing Chemoembolization
Body Composition Analysis by Bioelectrical Impedance Vector Analysis in Patients With Hepatocellular Carcinoma Undergoing Chemoembolization.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 21 (actual)
- Sponsor
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Hepatocellular carcinoma represents 80-90% of primary hepatic malignant tumors. 80% of patients with hepatocellular carcinoma are associated with cirrhosis. Chemoembolization is a process in which a chemotherapeutic agent is deposited directly into the hepatic tumor where the principal artery is embolized. Bioelectrical impedance bases its evaluation in a model where the body is conformed by two different compartments: fat mass and fat free mass. Bioelectrical impedance is complemented by vectorial analysis, which is independent to the state of hydration and is helpful to monitor any changes in corporal composition. It can be used as a control for the interpretation of the bioelectrical impedance.
Conditions
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2015-08-01
- Completion
- 2016-03-01
- First posted
- 2013-01-29
- Last updated
- 2016-06-08
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01777698. Inclusion in this directory is not an endorsement.